Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-12 10:36 am Purchase | 2025-03-31 | 13G | Moderna, Inc. MRNA | FMR LLC | 21,130,029 5.500% | 21,130,029 (New Position) | Filing History |
| 2025-04-30 06:47 am Sale | 2025-03-31 | 13G | Moderna, Inc. MRNA | BAILLIE GIFFORD & CO | 24,948,558 6.500% | -13,941,013 (-35.85%) | Filing History |
| 2025-02-12 09:07 am Sale | 2024-12-31 | 13G | Moderna, Inc. MRNA | BAILLIE GIFFORD & CO | 38,889,571 10.100% | -6,764,956 (-14.82%) | Filing History |
| 2024-04-10 2:03 pm Purchase | 2024-03-28 | 13G | Moderna, Inc. MRNA | The Vanguard Group | 39,036,765 10.200% | 5,129,791 (+15.13%) | Filing History |
| 2024-02-13 5:09 pm Purchase | 2023-12-29 | 13G | Moderna, Inc. MRNA | The Vanguard Group | 33,906,974 8.890% | 6,624,801 (+24.28%) | Filing History |
| 2024-02-07 08:42 am Purchase | 2023-12-31 | 13G | Moderna, Inc. MRNA | Bancel Stephane | 30,384,866 7.800% | 1,233,064 (+4.23%) | Filing History |
| 2024-01-29 3:26 pm Sale | 2023-12-31 | 13G | Moderna, Inc. MRNA | BlackRock Inc. BLK | 25,301,057 6.600% | -814,167 (-3.12%) | Filing History |
| 2024-01-29 10:49 am Purchase | 2023-12-29 | 13G | Moderna, Inc. MRNA | BAILLIE GIFFORD & CO | 45,654,527 11.970% | 867,781 (+1.94%) | Filing History |
| 2023-02-10 4:42 pm Sale | 2022-12-31 | 13G | Moderna, Inc. MRNA | Bancel Stephane | 29,151,802 7.410% | -2,386,382 (-7.57%) | Filing History |
| 2023-02-09 11:27 am Sale | 2022-12-30 | 13G | Moderna, Inc. MRNA | The Vanguard Group | 27,282,173 7.100% | -144,397 (-0.53%) | Filing History |
| 2023-01-31 5:52 pm Sale | 2022-12-31 | 13G | Moderna, Inc. MRNA | BlackRock Inc. BLK | 26,115,224 6.800% | -1,546,249 (-5.59%) | Filing History |
| 2023-01-19 11:25 am Sale | 2022-12-30 | 13G | Moderna, Inc. MRNA | BAILLIE GIFFORD & CO | 44,786,746 11.660% | -985,333 (-2.15%) | Filing History |
| 2022-02-14 3:00 pm Sale | 2021-12-31 | 13G | Moderna, Inc. MRNA | Flagship Ventures Fund IV General Partner LLC | 20,008,540 4.900% | -13,134,971 (-39.63%) | Filing History |
| 2022-02-14 08:01 am Purchase | 2021-12-31 | 13G | Moderna, Inc. MRNA | Bancel Stephane | 31,538,184 7.640% | 2,878,726 (+10.04%) | Filing History |
| 2022-02-10 08:27 am Purchase | 2021-12-31 | 13G | Moderna, Inc. MRNA | The Vanguard Group | 27,426,570 6.760% | 4,054,715 (+17.35%) | Filing History |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Moderna, Inc. MRNA | BlackRock Inc. BLK | 27,661,473 6.800% | 8,270,748 (+42.65%) | Filing History |
| 2022-01-26 10:26 am Purchase | 2021-12-31 | 13G | Moderna, Inc. MRNA | BAILLIE GIFFORD & CO | 45,772,079 11.290% | 1,080,693 (+2.42%) | Filing History |
| 2021-07-12 08:29 am Sale | 2021-06-30 | 13G | Moderna, Inc. MRNA | BlackRock Inc. BLK | 19,390,725 4.800% | -1,085,989 (-5.30%) | Filing History |
| 2021-03-01 11:26 am Purchase | 2021-02-26 | 13G | Moderna, Inc. MRNA | BAILLIE GIFFORD & CO | 44,691,386 11.180% | 20,379,115 (+83.82%) | Filing History |
| 2021-02-16 5:02 pm Sale | 2020-12-31 | 13G | Moderna, Inc. MRNA | Flagship Ventures Fund IV General Partner LLC | 33,143,511 8.400% | -17,865,181 (-35.02%) | Filing History |